Functional amino acid derivative-based small molecular compound library manufacturing technology
Sustainable drug pipeline with expandable novel compound library
A global pharmaceutical company developing innovative new drugs to overcome microbial infectious diseases and related diseases
Developing innovative new drugs for treating/preventing microbial infectious diseases that threaten human health and life
Improving responsiveness to new infectious diseases from newly identified pathogenic strains/mutant strains caused by environmental changes such as global warming
Providing social value by contributing to building an accessible value chain for underprivileged areas and classes
AmtixBio develops innovative drugs based on virulence factors based microbial infection targetsto build sustainable responsiveness to microbial infectious diseases and related inflammatory diseases.
